Podcasts about ccta

Chris’s Summary Jim and I are joined again by Dr. Philip Snyder as we continue looking at narrowing the gap between healthspan and lifespan and extending your go-go years. We discuss a listener-submitted article on health-adjusted life expectancy, which argues for concentrating retirement spending in the first decade of retirement rather than following a static, Monte Carlo-based safe withdrawal rate. Dr. Snyder updates his coronary artery calcium scoring correction, introduces the CCTA angiogram for non-calcified plaque, and outlines the four components of exercise, cardio, strength, balance, and flexibility, for maintaining function as we age. Jim’s “Pithy” Summary Chris and I welcome back Dr. Philip Snyder to pick up right where we left off, because folks, this whole thing, all of it, is about extending your go-go years, and I’ll admit this episode gave me some homework of my own. Dr. Snyder corrects something he got wrong last time on coronary artery calcium scoring, breaks down a newer angiogram option for catching the sneaky non-calcified plaque a clean CAC score can miss, and even mentions a blood test called PLAC2 for folks who can’t do the angiogram. A listener sent in a short article about spending more in your first decade of retirement instead of hoarding it for some rainy day that never comes, and it is basically what I have been calling the Fun Number for years. You spend your whole life saving, and then you’re too scared to spend it. My dad used to warn me about the Debbie Downers in his retirement community, folks with plenty of money left but no health left to enjoy it. Nobody wants to be that person, and nobody wants to be the wealthiest person in the graveyard either. Dr. Snyder walks through the four pieces of exercise you need as you get older, cardio, strength, balance, and flexibility, and Chris and I both admit we need a grease gun just to get moving some mornings. We get into tai chi, stretching, why I still cannot make myself do it consistently, and why one-third of people who break a hip never fully bounce back. Show Notes: “The First Decade Retirement Plan” article The post Extending Your Go-Go Years: EDU #2633 appeared first on The Retirement and IRA Show.

Book a free consultation call with Robert Sikes to break through your keto or low-carb plateau: https://www.ketobodybuilding.com/callYour heart was built to burn fat, not sugar, and losing that ability may drive heart disease. In episode 909 of the Savage Perspective Podcast, host Robert Sikes and Dr. Anthony Jay break down how insulin resistance can leave the heart low on fuel as LDL cholesterol and artery plaque rise. They cover HOMA-IR, statins, coronary calcium scans, CCTA, familial hypercholesterolemia, Lp(a), seed oils, inflammation, and microplastics. Dr. Jay shares why low LDL may not fix the root cause, when statins can help, and how fasting, a low-carb diet, and metabolic flexibility may support heart health. Watch to learn which tests matter and what common heart advice may miss.Buy Anthony's new book: https://amzn.to/4xycguPFollow on IG: https://www.instagram.com/anthonygjay/Get Keto Brick: https://www.ketobrick.com/Subscribe to the podcast: https://open.spotify.com/show/42cjJssghqD01bdWBxRYEg?si=1XYKmPXmR4eKw2O9gGCEuQChapters0:00 - Why Dr. Anthony Jay Took On Heart Disease1:04 - Does Insulin Resistance Cause Heart Disease?5:21 - How Do You Test for Insulin Resistance?8:43 - What Is the “Starving Heart” Theory?10:48 - Why Can a High-Fat Diet Raise LDL Cholesterol?13:02 - Do Statins Increase Coronary Calcium?16:21 - How Accurate Are CCTA and AI Plaque Scans?24:24 - When Is a Coronary Angiogram Actually Worth It?27:09 - When Do Statins Actually Help?29:33 - What Counts as True Familial Hypercholesterolemia?34:18 - Why Did Oreo Cookies Lower LDL Cholesterol?36:30 - Can Statins and Repatha Raise Diabetes Risk?38:17 - Can Fat Burning Help Reverse Artery Plaque?42:50 - Can Fasting Reverse Insulin Resistance and Plaque?44:34 - Which Heart Disease Risks Do Standard Tests Miss?46:00 - What Is Lp(a), and Why Does It Rise?48:22 - Is Lp(a) Really Genetic and Unchangeable?53:01 - Are Seed Oils Bad for Your Arteries?55:42 - Can Blood Tests Really Measure Inflammation?1:00:47 - How Long Do Seed Oils Stay in Your Body?1:03:31 - Why Do Experts Disagree About Seed Oils?1:06:07 - Should Healthy People Worry About Restaurant Seed Oils?1:08:40 - Is Alzheimer's Really Type 3 Diabetes?1:10:43 - How Do Plastics and Polyester Disrupt Hormones?1:12:14 - Are Microplastics Hiding Inside Artery Plaque?1:17:37 - Dr. Anthony Jay's New Book, Sugar Beat

Episode 2839 - Vinnie Tortorich and Chris Shaffer discuss challenging yourself, the benefits of CCTA scans, and reversing plaque in arteries. https://vinnietortorich.com/2026/08/benefits-of-ccta-scans-episode-2839 PLEASE SUPPORT OUR SPONSORS Pure Vitamin Club Pure Coffee Club NSNG® Foods VILLA CAPPELLI EAT HAPPY KITCHEN YOU CAN WATCH THIS EPISODE ON YOUTUBE - @FitnessConfidential Podcast Vinnie's workout videos are available to purchase! Choose from a 2-day, 4-day, or 6-day workout–or buy all three at a discount! TO PURCHASE VINNIE'S WORKOUT VIDEOS, CLICK THIS LINK: https://vinnietortorich.com/workout Always Be Learning Last year, Vinnie and Serena went on a vacation for the first time in a very long time. (6:00) It was also the first time in a long time that Vinnie went water skiing. Once he recovered from an injury, he was inspired to return to the activities he hadn't done for years. (16:00) He shares a skiing story that is a reminder to keep getting up after failing. (20:00) Vinnie gives an update on getting creatine into Pure Vitamin Club's product line. (34:00) Benefits of CCTA Scans Vinnie is interested in learning more about reversal of plaque in the arteries. (37:00) For many years, medicine has stated that once plaque build-up happened, it could not be reversed. Chris summarizes an article from Cardiovascular Business Journal. (40:00) CCTA scans appear to show progression of disease in stages now, which was unavailable before. However, using the test should be limited since it uses contrast radiation. A CAC score tells you if you have plaque or not. The CCTA (Cardiac Computed Tomography Angiography) examines how much plaque, where it's located, and its progression. (50:00) Doctors and Big Pharma have been pushing Repatha. (52:00) It came out in 2016 and did basically nothing. And then, it's jumped 37% year over year. The company made $953 million in sales in the second quarter this year of Repatha alone. Many people are on multiple drugs. Many times some of the drugs are addressing symptoms caused by other drugs they are taking. (56:00) Never be passive about your health when consulting with your medical professional. Always advocate for yourself. (1:08:00) Check out the Aletha Hip HookTM that Vinnie uses to reduce pain and increase mobility: You can purchase your own through Vinnie's website here: https://vinnietortorich.com/hook Anna's products are now linked to PureVitamin Club's website. Look under the "Food and Snacks" section to purchase them there, too. https://purevitaminclub.com/collections/food-and-snacks Vinnie hopes to add other products as well, all of which will be health-related. The NSNG® VIP GROUP IS NOW CLOSED AGAIN AS OF SUNDAY, MARCH 15TH Anna's next cookbook, Eat Happy Cocktail Hour, is filled with cocktails, mocktails, and appetizers and is available for pre-order right now. If you pre-order, you'll get bonus goodies! You can pre-order from a wide variety of booksellers at https://eathappycocktailhour.com/ Please save your receipt from wherever you pre-order; you'll need it for your bonuses! Physical Release Date is October 2026 You can book a consultation with Vinnie to get guidance on your goals. https://vinnietortorich.com/phone-consultation-2/ More News Serena has added some of her clothing suggestions and beauty product suggestions to Vinnie's Amazon Recommended Products link. Self Care, Beauty, and Grooming Products that Actually Work! https://www.amazon.com/shop/vinnietortorich/list/3GPVU29UHHPMY?ref_=aipsflist Don't forget to check out Serena Scott Thomas on Days of Our Lives on Peacock. "Dirty Keto" is available on Amazon! You can purchase or rent it here.https://amzn.to/4d9agj1 Please make sure to watch, rate, and review it! Eat Happy Italian, Anna's second cookbook, is available! You can go to https://eathappyitalian.com You can order it from Vinnie's Book Club. https://amzn.to/3ucIXm Anna's recipes are in her cookbooks, on her website, and on Substack —they will spice up your day! https://annavocino.substack.com/ PURCHASE DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries Then, please share my fact-based, health-focused documentary series with your friends and family. Additionally, the more views it receives, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: https://vinnietortorich.com/documentaries

Dr. Gary McGowan drops in to share a masterclass on cardiovascular disease and its major risk factors, including:The relationship between cholesterol and cardiovascular diseaseWhy LDL cholesterol is importantWhat causes LDL cholesterol to riseThe dietary factors that can increase LDL cholesterolNavigating misleading claims about LDL from the carnivore diet communityWhy elimination diets can appear to improve someone's healthThe relationship between obesity and cardiovascular diseaseWhy not all fat storage in the body is associated with the same level of disease riskVisceral fat, BMI, and the personal fat thresholdWhy cardiovascular risk accumulates over timeThe role of genetics in cholesterol and blood pressureWhat causes high blood pressureThe role of dietary sodium in hypertensionThe most important lifestyle behaviours for lowering cardiovascular disease riskHow to screen for atherosclerotic plaque buildup in your arteriesCoronary artery calcium scans and CCTA imagingWhether caffeine and energy drinks increase the risk of heart problemsAnd much moreFollow Gary on Instagram:@drgarymcgowanCHAPTERS01:31 Cholesterol and Heart Risk04:50 Why LDL Rises06:23 Diet Drivers of LDL09:31 Coffee and Cholesterol10:32 Exercise and Lipids12:19 Carnivore LDL Debate18:32 Elimination Diet Reality21:48 Obesity and Heart Disease26:26 Visceral Fat and BMI31:15 BMI Reality Check32:24 Personal Fat Threshold32:46 Obesity Over Time33:58 Cumulative Risk Model34:58 Blood Pressure Drivers36:04 Salt and the Modern Diet38:21 Lifestyle Risk Pillars38:53 Heart Plaque Screening41:32 Calcium Scans Explained44:33 CCTA for Soft Plaque48:17 Caffeine and Heart Risk53:14 Energy Drink Extremes55:21 Where to Find Gary57:34 Final Wrap-UpSUPPORT THE SHOWIf this episode helped you better understand cholesterol, blood pressure, or cardiovascular disease risk, you can support the show by:Subscribing and checking out more episodesSharing it on social media — tag me and I'll respondSending it to someone who is confused about cholesterol, blood pressure, or heart healthFOLLOW ANDREW COATESInstagram: @andrewcoatesfitnesshttps://www.andrewcoatesfitness.comPARTNERS AND RESOURCESRP STRENGTH APPUse code COATESRP:https://www.rpstrength.com/coatesJUST BITE ME MEALSUse code ANDREWCOATESFITNESS for 10% off:https://justbitememeals.comMACROSFIRST – FREE PREMIUM TRIALDownload MacrosFirst and during setup you'll be asked:“How did you hear about us?”Type in the code: ANDREWKNKG BAGS – 15% OFFhttps://www.knkg.com/Andrew59676VERSA GRIPPShttps://www.versagripps.com/andrewcoatesTRAINHEROIC – FREE 90-DAY TRIALComplete these two steps:Go to:https://www.trainheroic.com/liftfreeReply to the email you receive — or email trials@trainheroic.com — and let them know Andrew sent you.L1 BIOMECHANICS AND ASSESSMENT COURSEUse code COATES:https://pro.activelifeprofessional.com/assessmentworkshopevents

In this episode of Parallax, Dr Ankur Kalra is joined by Dr Matthew Budoff, Professor of Medicine at the David Geffen School of Medicine at UCLA and a leading authority on preventive cardiology and cardiac imaging. Together they examine the role of cardiac CT in detecting silent atherosclerosis, and ask whether imaging should displace traditional risk scores in routine practice. Dr Budoff makes the case for the coronary calcium score as the foundation of personalised cardiovascular care, arguing that population-based risk factors often fail at the individual level. He weighs the calcium score against CT angiography in primary prevention - covering cost, radiation, the uncertain significance of trivial plaque, and the risk of inappropriate stenting in asymptomatic patients - while noting that symptomatic patients warrant CCTA first-line. He also addresses elevated Lp(a) with a zero score and the case for CCTA in younger high-risk patients, before outlining his scalable, score-tiered approach to therapy, drawing on data from the VESALIUS trial. Is the calcium score ready to replace traditional risk scores? When should imaging guide therapy, and when should it be deferred? Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

CardioNerds Dr. Joseph Kassab, Dr. Mariana Garcia-Arango, and Dr. Christopher Mason explore the technological revolution of Coronary CT Angiography (CCTA) with expert faculty Dr. Michael Gallagher. The discussion details how CCTA has evolved into a frontline diagnostic and preventive tool, moving beyond simple anatomy to incorporate physiology via CT-FFR and biology through AI-driven plaque quantification. The episode reviews landmark evidence like the SCOT-HEART and PROMISE trials, the nuances of CAD-RADS 2.0 reporting, and the emerging role of AI in monitoring treatment response and personalizing cardiovascular care. Critically, they also discuss some of the assumptions and limitations of these techniques. Stay tuned for a matching review article to be submitted to US Cardiology Review, the official Journal of CardioNerds. This episode was supported by an independent medical education grant from HeartFlow. All CardioNerds education is planned, produced, and reviewed solely by CardioNerds.  Enjoy this Circulation Paths to Discovery article to learn more about the CardioNerds mission and journey. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscripts here. CardioNerds Multimodality Cardiovascular Imaging PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll Pearls Shift in Paradigm: CCTA is no longer just an anatomic test; with some key limitations, it can provide anatomy, physiology (CT-FFR), and plaque biology (AI-CPA) in a single non-invasive scan. The “Power of Zero” vs. Plaque: While a normal CCTA has a >95% negative predictive value, future MIs often arise from non-obstructive plaque that traditional stress tests might miss. CAD-RADS 2.0 Utility: The addition of plaque burden modifiers (P1–P4) is a “game changer,” allowing clinicians to identify high-risk patients who need aggressive lipid-lowering despite having only mild stenosis. CT-FFR as a Virtual Stress Test: CT-FFR uses computational fluid dynamics to simulate blood flow, potentially reducing unnecessary invasive catheterizations by approximately 61% without sacrificing safety. Seeing the Invisible: AI-based quantitative plaque analysis (QCPA) can identify “subvisual” plaque and low-attenuation (lipid-rich) components that are the primary drivers of acute coronary syndromes. Show Notes How has the role of CCTA changed compared to traditional functional testing? Historically, stress testing answered “is there ischemia today?”, which often reflects late-stage disease. CCTA identifies disease across the entire spectrum, asking “is there atherosclerosis and how much plaque is present?”. Landmark evidence: SCOT-HEART showed a 41% relative risk reduction in MI at 5 years attributed to intensified preventive therapies, and PROMISE showed CCTA was better at selecting patients who truly needed invasive angiography. Diagnostic CCTA imaging depends on the protocol, contrast timing, heart rate, heart rhythm, breathholding, scanner quality, and several patient factors (obesity, prior stents, heavy calcification, complex bypass anatomy, and motion artifact all may limit imaging). “CCTA is exceptional for the right patient, with the right scanner, and the right team.” What are the key modifiers introduced in CAD-RADS 2.0, and why do they matter? CAD-RADS 2.0 moved beyond stenosis severity to include plaque burden (P0 to P4), high-risk plaque (HRP) features, and the presence of ischemia based on CT-FFR. It serves as a clinical decision support tool: a patient with mild (25-49%) stenosis but “extensive” (P4) plaque burden is considered high risk and warrants aggressive risk factor modification. How is CT-FFR calculated, and when is it most useful in clinical practice? CT-FFR uses resting CCTA data and computational fluid dynamics to create a 3D model of coronary flow during simulated maximal hyperemia. It is often used for intermediate lesions (40–90% stenosis) to predict if they are  ischemia-producing, guiding the decision whether to proceed with invasive angiography.  The assumptions necessary for this computational modeling may not apply well to patients with microvascular dysfunction, significant myocardial scar or prior infarction, or ventricular hypertrophy. Still, data indicate that CT-FFR performs similarly to PET in predicting hemodynamically significant lesions.  CT-FFR performs well at the extremes (either clearly normal or clearly abnormal). Accuracy dips, however, in the intermediate range (~0.75-0.80), where decision-making is most critical. In this grey zone, additional factors can help guide the approach, including the amount of myocardium supplied, translesional gradient, and plaque features.   CT-FFR has not been validated in distal segments, stented segments, heavily calcified coronary arteries, or in patients with severe aortic stenosis. Caution with CT-FFR should be utilized in very calcified coronary segments.  What is AI-based quantitative plaque analysis (QCPA), and what metrics are ready for clinical use? This is potentially a paradigm shift, moving away from stenosis-centric thinking to a more disease burden and plaque biology focus. QCPA uses deep learning algorithms to automatically segment the vessel wall and quantify plaque volume in mm³. Ready for “prime time” metrics include: Total Plaque Volume (TPV), non-calcified plaque volume, and Low-Attenuation Plaque (LAP) burden. Can serial CCTA be used to monitor the effectiveness of medical therapies like statins? While not yet a routine guideline-driven practice, trials like PARADIGM and EVAPORATE show that therapies can stabilize plaque; notably, CCTA is better for monitoring than CAC scores, which can be misleading as statins often increase plaque calcification as part of the stabilization process. There are no randomized trials that serial CCTAs improve outcomes. Cost and radiation exposure will be notable limitations. Serial scan timing, scan acquisition and interpretation standardization would be key. Dr. Gallagher notes that we are moving toward a world in which plaque burden may become a “treatment biomarker,” similar to tumor burden in oncology.  References 1. Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies: JACC State-of-the-Art Review. Abdelrahman KM, Chen MY, Dey AK, et al. Journal of the American College of Cardiology. 2020;76(10):1226-1243. doi:10.1016/j.jacc.2020.06.076. 2. Non-Invasive Imaging in Coronary Syndromes: Recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in Collaboration With the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Edvardsen T, Asch FM, Davidson B, et al. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 2022;35(4):329-354. doi:10.1016/j.echo.2021.12.012. 3. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Gulati M, Levy PD, Mukherjee D, et al. Journal of the American College of Cardiology. 2021;78(22):e187-e285. doi:10.1016/j.jacc.2021.07.053. 4. Contemporary, Non-Invasive Imaging Diagnosis of Chronic Coronary Artery Disease. van der Bijl P, Gulati M, Saraste A, et al. Lancet (London, England). 2025;406(10519):2577-2587. doi:10.1016/S0140-6736(25)01586-7. 5. State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association. Slipczuk L, Blankstein R, Bucciarelli-Ducci C, et al. Circulation. 2025;152(23):e443-e466. doi:10.1161/CIR.0000000000001394. 6. Diagnostic Performance of Fractional Flow Reserve Derived From Coronary CT Angiography: The ACCURATE-CT Study. Li C, Hu Y, Jiang J, et al. JACC. Cardiovascular Interventions. 2024;17(17):1980-1992. doi:10.1016/j.jcin.2024.06.027. 7. Clinical Outcomes Based on Coronary Computed Tomography-Derived Fractional Flow Reserve and Plaque Characterization. Sato Y, Motoyama S, Miyajima K, et al. JACC. Cardiovascular Imaging. 2024;17(3):284-297. doi:10.1016/j.jcmg.2023.07.013. 8. Clinical Use of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Expert Consensus by an International Working Group. Tang CX, Leipsic JA, Nørgaard BL, et al. European Radiology. 2026;:10.1007/s00330-025-12313-6. doi:10.1007/s00330-025-12313-6. 9. Diagnostic accuracy of computed tomography–derived fractional flow reserve: a systematic review. Cook CM, Petraco R, Shun-Shin MJ, et al. JAMA Cardiol. 2017;2(7):803-810. Doi:10.1001/jamacardio.2017.1314 10. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). Nørgaard BL, Leipsic J, Gaur S, et al. J Am Coll Cardiol. 2014;63(12):1145-1155. Doi:10.1016/j.jacc.2013.11.043 11. Comparison of coronary computed tomography angiography, fractional flow reserve, and perfusion imaging for ischemia diagnosis. Driessen RS, Danad I, Stuijfzand WJ, et al. J Am Coll Cardiol. 2019;73(2):161-173. Doi:10.1016/j.jacc.2018.10.056. 12. 1-year outcomes of FFRCT-guided care in patients with suspected coronary disease: the PLATFORM study. Douglas PS, De Bruyne B, Pontone G, et al. J Am Coll Cardiol. 2016;68(5):435-445. Doi:10.1016/j.jacc.2016.05.057. 13. Comparison of an initial risk-based testing strategy vs usual testing in stable symptomatic patients with suspected coronary artery disease: the PRECISE randomized clinical trial. Douglas PS, Nanna MG, Kelsey MD, et al; PRECISE Investigators. JAMA Cardiol. 2023;8(10):904-914. Doi:10.1001/jamacardio.2023.2595. 14. Diagnostic and clinical value of FFRCT in stable chest pain patients with extensive coronary calcification: the FACC study. Mickley H, Veien KT, Gerke O, et al. JACC Cardiovasc Imaging. 2022;15(6):1046-1058. doi:10.1016/j.jcmg.2021.12.010. 15. Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART). Williams MC, Kwiecinski J, Doris M, et al. Circulation. 2020;141(18):1452-1462. doi:10.1161/CIRCULATIONAHA.119.044720. 16. AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD. Nurmohamed NS, Bom MJ, Jukema RA, et al. JACC. Cardiovascular Imaging. 2024;17(3):269-280. doi:10.1016/j.jcmg.2023.05.020. 17. Interaction of AI-Enabled Quantitative Coronary Plaque Volumes on Coronary CT Angiography, FFRCT, and Clinical Outcomes: A Retrospective Analysis of the ADVANCE Registry. Dundas J, Leipsic J, Fairbairn T, et al. Circulation. Cardiovascular Imaging. 2024;17(3):e016143. doi:10.1161/CIRCIMAGING.123.016143. 18. Prognostic Value of AI-Based Quantitative Coronary CTA vs Human Reader-Based Visual Assessment: Results From the CONFIRM2 Registry. van Rosendael A, Nakanishi R, Bax JJ, et al. JACC. Cardiovascular Imaging. 2026;19(3):345-359. doi:10.1016/j.jcmg.2025.09.021.13. Pericoronary Adipose Tissue as a Marker of Cardiovascular Risk: JACC Review Topic of the Week. Tan N, Dey D, Marwick TH, Nerlekar N. Journal of the American College of Cardiology. 2023;81(9):913-923. doi:10.1016/j.jacc.2022.12.021. 19. Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: Final Results of the EVAPORATE Trial. Budoff MJ, Bhatt DL, Kinninger A, et al. European Heart Journal. 2020;41(40):3925-3932. doi:10.1093/eurheartj/ehaa652. 20. Coronary CT Angiography Evaluation With Artificial Intelligence for Individualized Medical Treatment of Atherosclerosis: A Consensus Statement From the QCI Study Group. Schulze K, Stantien AM, Williams MC, et al. Nature Reviews. Cardiology. 2026;23(2):100-115. doi:10.1038/s41569-025-01191-6.

The Cholesterol Code is a gripping new documentary from Jennifer Isenhart that challenges one of medicine's most entrenched beliefs. Following Dave Feldman's unexpected health journey, the film dives into the controversy around cholesterol, uncovering new research and raising a powerful question: what if we've misunderstood it all along? In this episode, Dr. Tro, Jennifer, and Dave talk about… (00:00) Intro (02:39) How the upcoming documentary film, The Cholesterol Code, came to be and how Jen crafted the film to be accessible to a wide audience (08:06) How Jen turns scientific data into an engaging film (15:33) The effort and passion Dave Feldman has poured into his research (17:49) Why YOU should watch this film (Jen's answer) (22:37) How Dave went from a curious software engineer to being one of the main forces driving research on cholesterol and metabolic disease (26:24) Coining the term 'lean mass hyper-responder' and founding the Citizen Science Foundation (31:19) Dave Feldman's critics and how to push back against dogmatic medical authoritarianism (44:29) The good and the bad of cholesterol (01:00:36) LDL, ApoB, and plaque progression (01:06:36) Why YOU should watch The Cholesterol Code (Dave's answer) (01:08:06) CAC, CCTA, ApoB, and LDL levels (01:14:08) Medications that reduce arterial plaque (01:16:19) Arterial plaque and the keto diet (01:26:23) The biggest myths that were dispelled in The Cholesterol Code film (01:29:27) Medical professionals who have come around to Dave and Jen's perspective on cholesterol (01:33:32) Outro For more information, please see the links below. Thank you for listening! Links: Please consider supporting us on Patreon: https://www.lowcarbmd.com/ Resources Mentioned in this Episode: THE CHOLESTEROL CODE (documentary film): https://cholesterolcodemovie.com/the-film/ Jennifer Isenhart: The Cholesterol Code (film): https://cholesterolcodemovie.com/the-film/ Fat Fiction (film): https://fatfiction.movie/our-story Dave Feldman: The Cholesterol Code (film): https://cholesterolcodemovie.com/the-film/ Cholesterol Code (website): https://cholesterolcode.com/ X: https://x.com/realDaveFeldman Citizen Science Foundation: https://citizensciencefoundation.org/ Own Your Labs: https://ownyourlabs.com/ Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author Dr. Tro Kalayjian:  Website: https://toward.health Twitter: https://twitter.com/DoctorTro IG: https://www.instagram.com/doctortro/ Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.  Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://toward.health/community/

Show notes: (0:00) Intro (1:34) Dr. Voss's background and personal health story (3:48) What Longevity Health Clinic tests and why it is different (10:48) CCTA heart scans, AI plaque analysis, and deeper cholesterol testing (18:31) Full-body MRI benefits, limits, and what to watch for (30:17) Commonly missed tests, plaque reversal, and Repatha (40:14) Food, low-carb diets, red meat, fasting, and longevity (50:16) Where to find Dr. Vass and his resources (51:31) Outro Who is Dr. Vassily Eliopoulos?   Dr. Vassily Eliopoulos, M.D., also known as Dr. Vass, is the Co-Founder and Chief Medical Officer of Longevity Health in Colorado, where he focuses on preventive, longevity, and regenerative medicine. He earned a neuroscience degree with honors from Trinity College, then served as a Peace Corps volunteer in the Solomon Islands and worked with the World Health Organization on malaria and filariasis control projects. He later earned his medical degree at Cornell, completed a surgical internship at the University of Colorado, and finished an emergency medicine residency at Denver Health. After years as a board-certified emergency medicine physician, he shifted toward personalized, data-driven care designed to improve long-term health and performance. Connect with Dr. Vass Website: https://longevityhealth.clinic/ LinkedIn: https://www.linkedin.com/in/vassily-eliopoulos-m-d-5b8015143/ IG: https://www.instagram.com/dr.vassily/   Links and Resources: Peak Performance Life  Peak Performance on Facebook Peak Performance on Instagram  

Has your doctor told you your cholesterol is "too high" and it's time to take a statin, but you're other markers are squeaky clean, you're living a healthy diet and lifestyle, stress is under control, so you're a little skeptical why you're offered medication based on one number alone? We cover: Why atherosclerosis is a silent, decades-long process, and why symptoms often appear far too late How menopause changes the vascular landscape, nitric oxide, inflammation, and microvascular risk The difference between a calcium score and a CCTA with contrast, and which type of plaque matters The blood markers that matter more than total cholesterol The biggest myths in women's heart health Trained in conventional cardiology, Dr. Husain recognized early the limits of reactive medicine. That insight led him to pursue advanced training in preventive, functional, hormonal, and cellular-based therapies, integrating these disciplines into a deeply individualized approach to cardiovascular care. Beyond the clinic, he serves as an educator and scientific advisor, helping clinicians and organizations rethink how we assess cardiovascular risk, resilience, and overall long-term health. He is also a multi-sport athlete, artist, and lifelong learner, because he believes true health is not just measured in years lived, but in vitality, creativity, and meaning. Available to see new patients at Boulder Longevity Institute: https://boulderlongevity.com/about Upcoming Vascular medicine & Cardiology Health course for practitioners available at Next Generation Medicine https://www.nextgenerationmedicine.co/ Contact Dr. Abid Husain Instagram: @dr_abidhusain Facebook: @abid.husain.7712 LinkedIn: www.linkedin.com/in/abid-husain-md-facc-abaarm-00874419 Youtube: https://www.youtube.com/@DoctorAbidHusain Give thanks to our sponsors: Try Vitali skincare. 20% off with code ZORA here - https://vitaliskincare.com Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - https://www.oxfordhealthspan.com/ZORA Get Mitopure Urolithin A by Timeline. 20% discount with code ZORA at https://timeline.com/zora   Join the Hack My Age community on: YouTube: https://youtube.com/@hackmyage Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠   Biohacking Menopause Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠    For partnership inquiries: https://www.category3.ca/  Some episodes of Hack My Age are supported by partners whose products or services may be discussed during the show. The host may receive compensation or earn a minor commission if you purchase through affiliate links at no extra cost to you. All opinions shared are those of the host and guests, based on personal experience and research, and do not necessarily represent the views of any sponsor. Sponsorships do not imply medical endorsement or approval by any healthcare provider featured on this podcast.

Dr. Kim Brockenbrough: https://www.cardiavision.com/https://www.linkedin.com/in/kimberly-brockenbrough-md-1b321a123/https://www.instagram.com/kimbromd?ighsh=YjVpcDcwdHA3ejVvYour calcium score came back zero. You're in the clear, right? Not so fast.In this episode, Optispan Clinical Director Dr. Nicki Byrne sits down with Dr. Kim Brockenbrough, board-certified cardiovascular radiologist, 25-year veteran of vascular imaging, and CEO of CardiaVision, for a conversation that challenges one of the most common assumptions in preventive cardiology.If you care about cardiovascular longevity, and you should, because heart disease remains the leading killer, this is the imaging conversation you didn't know you needed.Timestamps:00:00 — Cold open: The 48-year-old runner with an 80% blockage and a zero calcium score00:54 — Dr. Nicki Byrne introduces Dr. Kim Brockenbrough & CardiaVision01:45 — Dr. Brockenbrough's background: 25 years of vascular imaging02:35 — Cardiovascular disease through a longevity lens: imaging vs. labs vs. functional testing03:24 — The lifecycle of plaque: from fatty deposits to rupture and heart attack04:21 — Why soft plaque is more dangerous than calcified plaque (SCOT-HEART 2020)05:14 — How calcium scores are used in clinical practice — and where they fall short06:18 — The only way to see soft plaque non-invasively: coronary CT angiography (CCTA)07:08 — Which populations are most at risk of a false sense of security from calcium scoring08:03 — What a CCTA can tell you that a calcium score can't09:43 — How often should patients follow up with repeat scans?10:28 — Higher vs. lower dose radiation protocols — and why Dr. Brockenbrough chooses higher dose11:17 — Risks of CCTA: contrast reactions, kidney considerations12:15 — Stress tests vs. CCTA: why a negative stress test is a very low bar13:21 — Soft plaque that isn't flow-limiting: small emboli, dementia, and congestive heart failure15:36 — Medications that reverse plaque: statins, PCSK9 inhibitors, and the LOCATE trial16:23 — LDL reduction and plaque regression: what the data shows17:08 — High-intensity statins vs. Repatha — tolerability, efficacy, and the price drop18:27 — When OptiSpan reaches for PCSK9 inhibitors: ApoB, LDL, Lp(a), ApoE4, and significant disease19:22 — Why a rising calcium score on a statin is exactly what you want to see20:25 — AI plaque quantification tools: promise, limitations, and validation concerns22:54 — Has AI ever changed Dr. Brockenbrough's read? A real-world case23:40 — FFR-CT, the ISCHEMIA trial, and why stenting asymptomatic patients is no longer standard of care25:25 — The future of cardiac imaging and the case for universal CCTA screening26:52 — The patient experience: what to expect at a CardiaVision CCTA appointment28:18 — Why seeing soft plaque changes patient behavior — the power of treating disease, not numbers29:49 — Bridging the gap between longevity medicine and traditional cardiology33:11 — Testosterone, the TRAVERSE trial, and what you should know about your coronaries first35:41 — What causes coronary artery disease beyond cholesterol: sugar, inflammation, gum disease37:07 — Image walkthrough: soft plaque vs. calcified plaque on a real CCTA41:36 — Where to find Dr. Brockenbrough and CardiaVision

  Radiation. Regions. Responsibility.

The limits of knowing coronary artery disease anatomy, fish oil and AF risk, a new drug for PSVT, and maybe I was wrong about a drug for AF conversion (the RAFF4 trial). These are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Prediction of CAD is hard — even if you have anatomy CCTA in Prediction of First Coronary Events https://jamanetwork.com/journals/jama/fullarticle/2841255 II Fish Oil and AF (and as a bonus we learn again about analytic flexibility) Are Fish Oils on the Hook for AF Risk? https://www.medscape.com/viewarticle/995290 Omega-3 and Fish Oil Use With Risk of AF  https://www.ahajournals.org/doi/full/10.1161/JAHA.125.043031 Effect of Long-Term Marine Omega-3 Fatty Acids on the Risk of AF https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.055654 RESPECT-EPA Trial https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.065520 Association Between Omega-3 Fatty Acids and AF: Meta Analysis https://link.springer.com/article/10.1007/s10557-021-07204-z Fish Oil Supplements and Risk of AF https://academic.oup.com/eurjpc/article/29/14/1911/6679610 Editorial: Fish Oil Supplements and AF Risk https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.057464 III A New Drug for PSVT FDA Approval https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-drug-type-abnormally-fast-heart-rhythm RAPID trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00776-6/fulltext IV AF Conversion with Vernakalant RAFF4 Trial https://www.bmj.com/content/391/bmj-2025-085632.long Editorial: Rapid Cardioversion for Acute AF https://www.bmj.com/content/391/bmj.r2264 VI A Quick Note on HFpEF Med Op-Ed: Avalanche Survival, HFpEF Skepticism, and More https://www.medscape.com/viewarticle/med-op-ed-avalanche-survival-hfpef-skepticism-and-more-2026a1000012 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

Ready to go beyond standard cholesterol panels and track what actually matters? Get your comprehensive performance bloodwork analysis at  witsandweights.com/bloodwork (code VITALITY20 for 20% off)—What if your blood work is missing the markers that truly predict long-term cardiovascular health? Can you build muscle, lose fat, and stay strong after 40 without risking your heart? And which biomarkers, hormones, and peptides actually move the needle for longevity and performance?I bring on Integrative Medicine & Cardiology Physician Dr. Abid Husain into the conversation, and we get into the evidence behind cardiovascular health for lifters, especially if you're focused on body recomp, strength training, weight loss, nutrition, and fitness. We cover the labs most people never get, how inflammation and metabolism shape heart health, and why tracking APOB, CRP, and oxidized LDL matters far more than total cholesterol. We also break down hormone health, HRT safety, muscle building over 40, and the peptides that actually support recovery and longevity.If you care about lifting weights, performance, and living longer with evidence-based fitness, this one gives you a clear roadmap. Tune in to learn more.Today, you'll learn all about:0:00 – Defining cardiovascular health3:40 – Mechanical vs biochemical heart health7:42 – Obesity, genetics, and heart disease12:10 – Key biomarkers to track18:55 – Inflammation patterns and risk23:20 – Cholesterol, genetics, and LDL nuance28:40 – Hormone health and HRT safety35:20 – Peptides for recovery and performance49:55 – Calcium scoring vs CCTA imaging*Episode resources:*Website: boulderlongevity.com Dr. Abid Husain's Instagram: @dr_abidhusain Boulder Longevity Institute's Instagram: @boulderlongevityinstitute LinkedIn: linkedin.com/in/abid-husain-md-facc-abaarm-00874419 YouTube: @boulderlongevityinstitute Facebook: @BoulderLongevityInstitute Support the show

On this “Meet the Experts” HeartTalk, host Melanie Lawson, MS, sits down with MedAxiom President and CEO Jerry Blackwell, MD, MBA, FACC, for a candid conversation about leadership, teamwork, and service – drawing lessons from both medicine and his early days in sports. He shares how trust and humility guide his approach and why he sees change as something to run toward, not from. Plus, he shares a few personal insights (and laughs) that reveal what keeps him grounded through it all.Guest Bio:Jerry Blackwell, MD, MBA, FACCPresident and CEO, MedAxiomAs the President and Chief Executive Officer (CEO) of MedAxiom, Jerry guides the course of the organization with a passion for physician leadership, teaching and care transformation – particularly team-based care and organizational performance improvement. He maintains a clinical practice with special interests in advanced imaging, including cardiovascular MRI, CCTA and cardiac PET.He has more than 30 years of experience in cardiovascular medicine, including academic cardiology, private practice and large integrated cardiovascular group leadership. Most recently, he served as executive vice president and chief clinical officer of the Ballad Health System. Blackwell has been involved with both MedAxiom and the American College of Cardiology (ACC) for many years. He has served on the ACC's Board of Governors, the Board of Directors for the Cardiology Advocacy Alliance, and the ACC's Health Affairs Committee.Blackwell graduated from Marshall University's Joan C. Edwards School of Medicine and completed residency/chief residency/fellowship at the Ohio State University and the University of Alabama - Birmingham. He earned his executive MBA from the University of Tennessee.Watch the episode here:https://youtu.be/DzbM7n75aVs

This week, Dr. Kahn breaks down new research presented at the American Heart Association linking melatonin use to congestive heart failure. Should you be concerned? He shares his expert perspective. Also in this episode: aspirin use in diabetes, fruit's role in Parkinson's disease, how metformin affects exercise results, the impact of heavy metals like mercury on heart health, why daily walking supports "Life's Essential 8" for Alzheimer's prevention, new CCTA data proving the benefits of statins, and how marriage might influence aging.  Don't forget to sample some high-quality olive oil at getfreshdrkahn.com.

The Truth About Cholesterol, LDL, and Plaque Regression with Dave Feldman | Lean Mass Hyper-Responder Research Explained What if everything you've been told about cholesterol and heart disease is incomplete — or even wrong? In this eye-opening episode of The Coach Debbie Potts Show, I sit down with Dave Feldman, engineer turned citizen scientist, founder of Own Your Labs and The Citizen Science Foundation, and the mind behind the Lean Mass Hyper-Responder (LMHR) study and the groundbreaking Keto-CTA trial on plaque progression and regression. We unpack the latest findings from Dave's multi-platform coronary imaging study — comparing HeartFlow, QAngio, Cleerly, and expert readouts — to explore how some individuals with very high LDL cholesterol and low inflammation show no increase in plaque and, in some cases, true regression. You'll learn:

This week, Dr. Kahn discussed a new paper about the power of a Zero Score Calcium CT Scan in people without symptoms but concerns for soft plaque (non-calcified) in those with symptoms. Generally, patients with symptoms are better tested by Coronary CT Angiograms (CCTA), optimally with FFR and Cleerly Software analysis. He provides case studies from the clinic. Other topics include plant diets for Crohn's Disease prevention, the goal of 7,000 steps a day, Lipoprotein(a) and stroke, heart and brain risk control benefits, strategies to avoid weight gain, and erythritol and heart disease.  Thanks to Igennus.com and the discount code DrKahn.

Join hosts Nidhi Madan, MD; Prashant Nagpal, MD, FSCCT; Jill Jacobs, MD, MS-HQSM, FSCCT and Cristina Fuss, MD, PhD, FSCCT as they take a deep dive into featured articles in the March – April 2025 issue of the Journal of Cardiovascular Computed Tomography (JCCT). Our hosts chat with Jonathan Weir McCall, MBChB, PhD, FRCR, FSCCT; Tilman Emrich, MD; Akos Varga-Szemes, MD, PhD; Emese Zsarnoczay, MD; David Wilson, PhD and Juhwan Lee, PhD . This episode will explore:A new business paradigm to make coronary CT angiography (CCTA) accessible to allPredicting Mortality After Transcatheter Aortic Valve Replacement Using AI-Based Fully Automated Left Atrioventricular Coupling IndexPrediction of obstructive coronary artery disease using coronary calcification and epicardial adipose tissue assessments from CT calcium scoring scansSupport the show

Despite being the leading cause of death, heart disease often receives less urgent attention than cancer. This episode delves into an integrative cardiology approach, exploring advanced diagnostics, personalized lifestyle interventions, and innovative therapies that are revolutionizing heart health and longevity.Today on the Vibrant Wellness podcast, hosts Dr. Emmie Brown, ND, and Melissa Gentile, INHC, welcome Dr. Giovanni Campanile, a Harvard-trained cardiologist and pioneer in integrative cardiology. Dr. Campanile, a "reformed interventional cardiologist," discusses his shift from traditional interventions to a practice focused on the prevention and reversal of heart disease by addressing underlying causes.Their conversation highlights the limitations of conventional risk factors and introduces "non-traditional" factors such as hormones, diet, exercise, and environmental toxins. Dr. Campanile stresses the importance of personalized lifestyle modifications, including varied exercise routines and a sensible, plant-rich Mediterranean-style diet. He also explains how the use of innovative diagnostic tools like CT coronary calcium scores and coronary CT angiography (CCTA) with AI-powered plaque analysis is crucial for precise risk assessment and monitoring disease progression. The episode also touches on AI EKGs for predicting biological age and arrhythmia risk, and explores the benefits of functional medicine modalities like hyperbaric oxygen therapy, sauna, cryotherapy, and photobiomodulation for enhancing vascular health and promoting vibrant wellness.Key Takeaways from Today's Episode:

In this industry-sponsored episode, host Praveen Ranganath, MD is joined by Yader Sandoval, MD and Jonathon Leipsic, MD, MSCCT, the chair and co-chair of the recently published inter-society roundtable document on CCTA for PCI planning. Conversation topics include the origin of this expert roundtable, the benefits of and evidence supporting CCTA for PCI planning, a deep-dive into heavily calcified and bifurcation lesion planning, and insights on how to tackle current barriers to adoption. Coronary Computed Tomography Angiography to Guide Percutaneous Coronary Intervention: Expert Opinion from a SCAI/SCCT RoundtableThis episode is sponsored by Heartflow. References to a specific product, process, or service by speakers in this podcast episode do not constitute or imply an endorsement by the Society of Cardiovascular Computed Tomography. The views and opinions expressed in do not necessarily reflect those of the Society of Cardiovascular Computed Tomography.

In this episode of the Smarter Not Harder Podcast, Dr. Abid Husain joins Dr. Scott Sherr for a masterclass on cardiovascular health — from cholesterol myths to mitochondrial truth. They explore what truly drives inflammation, plaque formation, and cardiovascular risk, while dismantling the outdated “cholesterol = heart disease” narrative. Whether you're a clinician or simply someone trying to make smarter choices for your heart, this episode offers insight into testing, interventions, and personalized strategies that go beyond basic lipid panels. Join us as we delve into: + Why LDL alone doesn't tell the full story of cardiovascular risk + How mitochondria, hormones, and inflammation intersect with lipid metabolism + The real role of CCTA scans, plaque imaging, and particle size analysis + Advanced medications and peptides that support vascular and metabolic health This episode is for you if: - You've been told to fear cholesterol but want the full picture - You're a practitioner looking to personalize cardiovascular treatment plans - You've heard of statins and PCSK9s but don't know when or why to use them - You're curious about GLP-1s, NO precursors, and other precision tools for heart health You can also find this episode on… YouTube: https://youtu.be/npYvJS2cpGc Find more from Dr. Abid Husain: Boulder Longevity: https://boulderlongevity.com LinkedIn: https://www.linkedin.com/in/abid-husain-md-facc-abaarm-00874419/ Find more from Smarter Not Harder: Website: https://troscriptions.com/blogs/podcast | https://homehope.org Instagram: @troscriptions | @homehopeorg Get 10% Off your purchase of the Metabolomics Module by using PODCAST10 at https://www.homehope.org Get 10% Off your Troscriptions purchase by using POD10 at https://www.troscriptions.com Get daily content from the hosts of Smarter Not Harder by following @troscriptions on Instagram.

Save 20% on all Nuzest Products WORLDWIDE with the code MIKKIPEDIA at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comThis week on the podcast, Mikki speaks to Dr. Matt Budoff – a world-renowned cardiologist and researcher who has spent decades at the forefront of cardiovascular imaging and prevention. Known for his pioneering work in coronary artery calcium (CAC) scoring and computed tomography angiography (CCTA), Dr. Budoff has helped transform how we detect and assess heart disease risk.In this conversation, we explore what first sparked his interest in cardiovascular imaging and how his views on lipids, plaque, and heart disease risk have evolved over time. We dig into his recent research on lifestyle interventions—particularly low-carbohydrate and ketogenic diets—and how they affect LDL cholesterol, atherosclerosis, and overall coronary health.We also discuss the implications of his KETO study, which found no direct correlation between elevated LDL-C and plaque burden in lean, metabolically healthy individuals following a ketogenic diet.Dr. Matthew J. Budoff is a distinguished cardiologist and professor of medicine at the David Geffen School of Medicine at UCLA. He holds the Endowed Chair of Preventive Cardiology at Harbor-UCLA Medical Center and serves as the Program Director and Director of Cardiac CT in the Division of Cardiology Renowned for his pioneering work in non-invasive cardiovascular imaging, Dr. Budoff has significantly advanced the use of coronary artery calcium (CAC) scoring and computed tomography angiography (CCTA) to detect and monitor coronary artery disease. His research focuses on early detection methods for cardiac disease, aiming to identify high-risk patients and implement preventive strategies Dr. Budoff has authored or co-authored over 50 books and book chapters and more than 2,000 articles and abstracts. His contributions have been recognised with numerous awards, including the Gold Medal Award from the Society of Cardiovascular Computed Tomography and designation as a Master of the Society Matt Budoff https://profiles.ucla.edu/matthew.budoffLMHR https://www.jacc.org/doi/10.1016/j.jacadv.2024.101109  Curranz Supplement: Use code MIKKIPEDIA to get 20% off your first order - go to www.curranz.co.nz  or www.curranz.co.uk to order yours Contact Mikki:https://mikkiwilliden.com/https://www.facebook.com/mikkiwillidennutritionhttps://www.instagram.com/mikkiwilliden/https://linktr.ee/mikkiwilliden

This podcast is the first in a three-part series on integration of responder disciplines during an active threat with subject matter experts Jeff Borkowski, James Sellers, and Sam Shurley. In this episode, we discuss effective pre-planning and pre-incident communication, identifying key stakeholders, and barriers to building strong relationships between agencies.This series references modules or topics taught in LSU NCBRT/ACE's Active Threat Integrated Response Course (ATIRC) and Critical Decision Making for Complex Coordinated Terrorist Attacks (CCTA) class. Find more information on the ATIRC training here, and learn more about the CCTA course here.

This is the second of three episodes on active threat integration with Jeff Borkowski, James Sellers, and Sam Shurley. In this episode, we talk about what integration actually looks like during active threat response, including the challenges agencies may face and the roles/responsibilities of staging managers.This series references modules or topics taught in LSU NCBRT/ACE's Active Threat Integrated Response Course (ATIRC) and Critical Decision Making for Complex Coordinated Terrorist Attacks (CCTA) class. Find more information on the ATIRC training here, and learn more about the CCTA course here.

This is the final episode in our three-part series on active threat integration with Jeff Borkowski, James Sellers, and Sam Shurley. This episode covers the reunification stage of an integrated response to a threat, including the importance of communication with the public, potential challenges during the reunification process, and how agencies can prepare for this stage ahead of time.This series references modules or topics taught in LSU NCBRT/ACE's Active Threat Integrated Response Course (ATIRC) and Critical Decision Making for Complex Coordinated Terrorist Attacks (CCTA) class. Find more information on the ATIRC training here, and learn more about the CCTA course here.

Neste episódio do DozeCast, Mateus Prata e Raphael Rossi recebem novamente o Dr. Silvio Póvoa, um dos maiores nomes da cardiologia do esporte no Brasil, para discutir um tema polêmico e cada vez mais relevante: doença arterial coronariana (DAC) em atletas de endurance.

Coronary CT angiography-guided management of patients with stable chest pain: 10-year outcomes from the SCOT- HEART randomised controlled trial in Scotland Michelle C Williams, Ryan Wereski, Christopher Tuck, Philip D Adamson, Anoop S V Shah, Edwin J R van Beek, Giles Roditi, Colin Berry,Nicholas Boon, Marcus Flather, Steff Lewis, John Norrie, Adam D Timmis, Nicholas L Mills, Marc R Dweck, David E Newby, on behalf of theSCOT-HEART Investigators* Summary Background The Scottish Computed Tomography of the Heart (SCOT-HEART) trial demonstrated that management guided by coronary CT angiography (CCTA) improved the diagnosis, management, and outcome of patients with stable chest pain. We aimed to assess whether CCTA-guided care results in sustained long-term improvements in management and outcomes. Methods SCOT-HEART was an open-label, multicentre, parallel group trial for which patients were recruited from 12 outpatient cardiology chest pain clinics across Scotland. Eligible patients were aged 18–75 years with symptoms of suspected stable angina due to coronary heart disease. Patients were randomly assigned (1:1) to standard of care plus CCTA or standard of care alone. In this prespecified 10-year analysis, prescribing data, coronary procedural interventions, and clinical outcomes were obtained through record linkage from national registries. The primary outcome was coronary heart disease death or non-fatal myocardial infarction on an intention-to-treat basis. This trial is registered at ClinicalTrials.gov (NCT01149590) and is complete. Findings Between Nov 18, 2010, and Sept 24, 2014, 4146 patients were recruited (mean age 57 years [SD 10], 2325 [56·1%] male, 1821 [43·9%] female), with 2073 randomly assigned to standard care and CCTA and 2073 to standard care alone. After a median of 10·0 years (IQR 9·3–11·0), coronary heart disease death or non-fatal myocardial infarction was less frequent in the CCTA group compared with the standard care group (137 [6·6%] vs 171 [8·2%]; hazard ratio [HR] 0·79 [95% CI 0·63–0·99], p=0·044). Rates of all-cause, cardiovascular, and coronary heart disease death, and non-fatal stroke, were similar between the groups (p>0·05 for all), but non-fatal myocardial infarctions (90 [4·3%] vs 124 [6·0%]; HR 0·72 [0·55–0·94], p=0·017) and major adverse cardiovascular events (172 [8·3%] vs 214 [10·3%]; HR 0·80 [0·65–0·97], p=0·026) were less frequent in the CCTA group. Rates of coronary revascularisation procedures were similar (315 [15·2%] vs 318 [15·3%]; HR 1·00 [0·86–1·17], p=0·99) but preventive therapy prescribing remained more frequent in the CCTA group (831 [55·9%] of 1486 vs 728 [49·0%] of 1485 patients with available data; odds ratio 1·17 [95% CI 1·01–1·36], p=0·034). Interpretation After 10 years, CCTA-guided management of patients with stable chest pain was associated with a sustained reduction in coronary heart disease death or non-fatal myocardial infarction. Identification of coronary atherosclerosis by CCTA improves long-term cardiovascular disease prevention in patients with stable chest pain.

Can CT Angiography Be Used to Track CAD Regression?   Guest: Eric Williamson, M.D. Host: Stephen Kopecky, M.D.   Listeners to this podcast will learn about the role of coronary CT angiography (CCTA) in preventative cardiology. CCTA enables early detection and characterization of coronary plaque before significant cardiovascular events occur. It non-invasively visualizes both calcified and non-calcified plaques, allowing for a comprehensive assessment of coronary artery health. These early insights can inform lifestyle modifications and targeted therapies, ultimately reducing the risk of heart disease.   Topics Discussed: What is the role of coronary CTA in the assessment of coronary atherosclerotic plaque? What recent technological advancements have occurred to improve the characterization of coronary plaque? How is AI playing a role in plaque assessment using CT? What future developments will advance our use of CT for plaque assessment in the near future?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

Today's show is brought to you by MYOXCIENCE.  In this episode, heart surgeon and best selling author Dr. Phil Ovadia discusses the foods and lifestyle factors driving a new wave of early-onset heart disease. Sponsored by MYOXCIENCE: Support your Intermittent Fasting lifestyle with the Berberine Fasting Accelerator by MYOXCIENCE: https://bit.ly/berberine-fasting-accelerator Use code podcast to save 12% Link to full show notes and articles: https://bit.ly/3uKRKMC Connect with Dr. Ovadia: https://ifixhearts.com/quiz/ Show Notes: 0:00 Intro 1:30 Up to 95% of people with cardiac disease are insulin resistant. 4:45 Processed foods and high carbs are the two primary drivers of metabolic disease, the primary driver of heart disease. 6:53 Insulin resistance damages blood vessels. 11:18 Exercise is indirectly helpful in preventing atherosclerosis. 13:10 The better you can maintain muscle as you age, the better you can deal with the aging process. 14:30 It is possible to reverse atherosclerosis. 16:30 Tests: coronary artery calcium scan (CAC) and coronary CT angiogram (CCTA). 18:30 People in their 30s and 40s now end up on the cardiac operating table. 20:30 High LDL may not be dangerous in a person who is metabolically healthy. 21:00 The quality of your LDL particles is important. 22:54 90% of adults are metabolically unhealthy, so their high LDL is likely dangerous. 24:05 Statin use for over 10 years increases your risk of developing insulin resistance and type 2 diabetes, primary drivers of heart disease. 26:30 Inflammation is an important part of the development of heart disease. 27:40 High blood pressure root cause is insulin resistance/metabolic disease. 31:41 Ferritin testing measures total body iron stores. It is also an inflammation marker. 35:50 Linoleic acid LDL oxidation hypothesis 37:30 Plant-based diets 40:25 Lowering your intake of omega 6 improves your omega 3 index. 41:10 Low vitamin D 42:00 Sun exposure has been misunderstood. 44:10 Triglycerides is a higher risk than LDL. 48:30 Bioidentical hormones are superior to synthetic. 50:03 Low testosterone is a risk factor for heart disease. 53:10 Heart surgery does not fix the underlying problem.      

In this episode, Jian'an Wang examines a study on the predictive power of integrating fractional flow reserve computed tomography (FFR CT) and its local gradient in assessing future coronary events in patients. The findings suggest that this combined approach significantly enhances risk prediction, offering valuable insights for more informed clinical decision-making in managing coronary artery disease.

In this episode of Hart2Heart, Dr. Mike Hart welcomes back Dr. Kyle Gillette, a board-certified family medicine and obesity medicine physician. Together, they dicuss the fascinating realm of peptides, exploring their various forms, applications, and potential benefits. They also discuss the nuances of testosterone therapy, the importance of spiritual well-being, and the practice of forgiveness. Guest Bio and Links: Kyle Gillett, MD, a dual board-certified physician in family medicine and obesity medicine and an expert in hormone optimization and human performance.  Listeners can learn more about Dr. Kyle Gillett on IG @kylegillettmd Episodes Mentioned: Dr. Mike Hart and Kyle Gillett, MD  TRT, Heart Health, and Hair Loss with James O'Hara Dr. Anish Koka on The Vax, Blood Markers, and Daily Asprin Use All You Need To Know About The Controversial Oreo vs. Statin Study | Dr. Nick Norwitz Show Notes: (0:00) Welcome back to the Hart2Heart Podcast with Dr. Mike Hart    (0:15) Dr. Hart introduces Dr. Kyle Gillett to the listeners (0:30) Dr. Kyle Gillett's background (1:45) Exploring BPC 157 peptide (7:30) Eastern European peptides (10:00) Peptides and traumatic brain injury (15:30) Testosterone Therapy - when and how to get tested (17:00) Four stages of puberty  (20:00) Topical testosterone - absorption and application (26:30) Increasing androgen sensitivity (30:00) Testosterone and cardiovascular risks (36:00) Ways to increase and decrease androgine sensitivity  (42:00) Cholesterol testing - the best approach (49:00) Cholesterol lowering drugs - alternatives and considerations (51:30) Triglycerides and their impact on health (56:00) Nattokinase - a potential game changer (59:30) Mental health and spirituality - the power of forgiveness (1:03:00) Daily routines and final thoughts --- Dr. Mike Hart is a Cannabis Physician and Lifestyle Strategist. In April 2014, Dr. Hart became the first physician in London, Ontario to open a cannabis clinic. While Dr. Hart continues to treat patients at his clinic, his primary focus has shifted to correcting the medical cannabis educational gap that exists in the medical community.  Connect on social with Dr. Mike Hart: Social Links: Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart  

Dr. Gillett & James O'Hara react To Ken Berrys most recent lab results. 00:00 Intro01:02 Elevated CRP can be seen in individuals with metabolic dysfunction, even without a cold or flu.03:42 Exercise Factor: An A1C of 5.5 is seen in active individuals with low insulin levels.08:16 Cholesterol Levels: LDL particle numbers and small particles are high12:55 Cardiac Scanning: importance of advanced cardiac assessments like CCTA when standard tests return ambiguous results.21:59 Copper Levels: Liver consumption does not lead to copper toxicity; levels remain in the normal range.23:21 It's important not to overemphasize a single homocysteine level due to potential inaccuracies related to sample handling.25:12 A balanced omega-3 and omega-6 profile is desirable. 25:53 Low vitamin C isn't causing connective tissue issues or scurvy symptoms, contradicting common concerns.27:54 Serum vitamin C level isn't a sole indicator of scurvy; clinical signs must match.28:09 An accurate iodine status requires 24-hour urine collection rather than serum measurement.30:27 A coronary CT angiogram is suggested to check for subclinical atherosclerosis regardless of a zero calcium score.31:27 OutroCarnivore Diet Lab Results of Dr Berry & Nurse Neisha - 2024:► https://youtu.be/bFKs65QsugA?si=6s5WGQsJNu9GKaDyFor High-Quality Labs:► https://gilletthealth.com/order-lab-panels/For information on the Gillett Health clinic, lab panels, and health coaching:► https://GillettHealth.comFollow Gillett Health for more content from James and Kyle► https://instagram.com/gilletthealth► https://www.tiktok.com/@gilletthealth► https://twitter.com/gilletthealth► https://www.facebook.com/gilletthealthFollow Kyle Gillett, MD► https://instagram.com/kylegillettmdFollow James O'Hara, NP► https://Instagram.com/jamesoharanpFor 10% off Gorilla Mind products including SIGMA: Use code “GH10”► https://gorillamind.com/For discounts on high-quality supplements►https://www.thorne.com/u/GillettHealth#reaction #carnivore #diet #podcastAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Prediction models vs clinical judgement, CCTA quantification of atherosclerosis, AF ablation plus LAAO, atrial shunt devices, and HF medical therapy are topics John Mandrola, MD, covers this week. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I.Clinical Prediction Models vs Clinical Judgement Did Statin Decision-Making Just Get Harder?  https://www.medscape.com/viewarticle/did-statin-decision-making-just-get-harder-2024a1000egl Colunga-Lozano and colleagues https://doi.org/10.1016/j.jclinepi.2023.10.016 Aug 02, 2024 This Week in Cardiology Podcast https://www.medscape.com/viewarticle/1001429 II. CCTA Quantification of Atherosclerosis Atherosclerosis Quantification and Cardiovascular Risk: the ISCHEMIA Trial https://doi.org/10.1093/eurheartj/ehae471 Circulation ISCHEMIA sub study 2021 – Severity of CAD and Outcomes https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.049755 ISCHEMIA Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1915922 III. Combined AF Ablation and LAAO Review from Mills and colleagues https://doi.org/10.1016/j.tcm.2023.11.003 Link to CMS Rule on AF Ablation and LAAO https://hrs2.informz.net/z/cjUucD9taT05MjU3ODgyJnA9MSZ1PTkwMDQ2MTk4MCZsaT04NTU1OTQxMg/index.html IV. Atrial Shunt Devices No Net HF Benefit for Interatrial Shunt Device https://www.medscape.com/viewarticle/no-net-hf-benefit-interarterial-shunt-device-2024a10006kk Original REDUCE-LAP-HF-II https://doi.org/10.1016/S0140-6736(22)00016-2 Two-year results of REDUCE-LAP-HF-II https://doi.org/10.1016/j.jchf.2024.04.011 Apr 19, 2024 This Week in Cardiology Podcast V. Optimal HF Therapy Rao and colleagues; CHAMP HF https://doi.org/10.1016/j.jchf.2024.05.026 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

I read these for a living. Does a coronary CT angiogram show soft plaque in the arterial wall? Cardiologist who read CCTA and calcium scores explains. Why CT angio can miss soft plaque. https://dralo.net/links

In this bonus episode, Dr. Joel Kahn interviews Dr. James Min, founder and CEO of Cleerly Health. Cleerly Health is revolutionizing heart diagnostics with their software, which analyzes coronary CT angiograms (CCTA) using AI to detect and evaluate heart plaque. Not all plaque is equal, and Cleerly Health focuses on identifying non-calcified or "soft" plaques, which are the most dangerous and most likely to be reversible.  This cutting-edge technology has been employed hundreds of times at the Kahn Center, offering a new paradigm in heart health assessment and treatment.

Menopause and age raise our cardiovascular disease risk. Athletes and highly active people also tend to have a higher prevalence of coronary artery calcium and atherosclerotic plaque (though it tends to be the benign kind). But what does that all mean? How can we know what's really going on in those coronary arteries of ours? To find out, host Selene Yeager had a Cleerly-enabled coronary computed tomography angiography (CCTA), which uses AI-enabled software to help characterize coronary plaque composition and cardiovascular disease risk. This week, she sat down with Anita Vadria, MS, PA-C, who is the Director of Medical Science Liaisons and Clinical Education at Cleerly to go over her results, talk about plaque and heart disease risk, and how technology is helping advance our understanding of our personal risk. Anita Vadria, MS, PA-C, is the Director of Medical Science Liaisons and Clinical Education at Cleerly. She is a Board Certified Physician Assistant with a focus in Cardiology. She received her undergraduate degree in Molecular and Cell Biology and received her Masters in Physician Assistant Studies from Western University of Health Sciences in Los Angeles, CA.ResourcesImpact of atherosclerosis imaging-quantitative computed tomography on diagnostic certainty, downstream testing, coronary revascularization, and medical therapy: the CERTAIN study, hereAtherosclerosis Imaging Quantitative Computed Tomography (AI‐QCT) to guide referral to invasive coronary angiography in the randomized controlled CONSERVE trial, hereCoronary Artery Calcification Among Endurance Athletes “Hearts of Stone”, herePhysical Activity and Progression of Coronary Artery Calcification in Men and Women, hereMost heart attack patients' cholesterol levels did not indicate cardiac risk, here Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines, here2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic AdultsA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, hereHeart attacks with no obvious risk factors on the rise, hereSubscribe to the Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-page Follow Us on Instagram:Feisty Menopause: @feistymenopause Feisty Media: @feisty_media Selene: @fitchick3 Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099 Join Level Up - Our Community for Active Women Navigating the Menopause Transition:Join:...

Today Stephen dives into his story about his heart health. In November, 2023 he had a major heart scare that put him in the emergency cardiac floor for four days and has changed his outlook on life and on his health forever. We discuss symptoms of a heart attack, and preventative action steps to take to learn more about our own heart health. Resources discussed on this episode: https://www.heart.org/en/health-topics/heart-attack/warning-signs-of-a-heart-attack https://my.clevelandclinic.org/health/diagnostics/22770-troponin-test website about CAC vs CCTA testing: https://www.kahnlongevitycenter.com/blog/coronary-artery-calcium-score-vs-coronary-ct-angiogram-what-they-are-and-what-they-show Huberman Lab podcast w/ Dr Sara Gottfried: Jan 30, 2023 @2:25:00 Rich Roll podcast w/ Simon Hill: Jan 1, 2024 Living proof 10 Truths PDF: https://theproof.com/longevityscore/ https://cleerlyhealth.com/ https://www.insidetracker.com/ -- Join the TKM Reflections Group: www.thekineticman.com/signup Subscribe to our newsletter (The MENifesto): www.thekineticman.com/newsletter Get a monthly email with 3-minute videos from every podcast guest we have on The Kinetic Man Podcast that answers the most impactful action they have taken to Level-UP in their home & in their business: www.thekineticman.com/levelup Join our New Kinetic Man Facebook Group: https://www.facebook.com/groups/thekineticman

Answering questions from X (Twitter). XQ Can you take Mounjaro and Ozempic together?Does Victoza becoming generic matter? (liraglutide generic)Does LDL Particle Size Matter?How does a cardiologist assess CVD risk?When would you order an ECG, Echo, Stress, CAC, CCTA?If I do everything right, does Lp(a) still matter?Why do surgeon medfluencers comment on medical topics?Should we stent asymptomatic 65% lesions in coronary arteries? https://dralo.net/links

This week in the HotBox, we chat with Jeremy Smith, the Director of Government Relations for the Canadian Cannabis Tourism Alliance (CCTA). We discuss the significance of cannabis tourism and on all sectors of our economy. Canada has the opportunity to become the world's number one cannabis tourism destination if done right. The CCTA is doing the hard work to make that happen. Follow the CCTA on IG @CannabisTourismCanadaSupport the show

Heart Surgeon and best selling author Dr. Phil Ovadia discusses the foods and lifestyle factors driving a new wave of early-onset heart disease. Sponsored: Support your Intermittent Fasting lifestyle with the Berberine Fasting Accelerator by MYOXCIENCE: https://bit.ly/berberine-fasting-accelerator Use code podcast to save 12% Link to full show notes and articles: https://bit.ly/3uKRKMC Connect with Dr. Ovadia: https://ifixhearts.com/quiz/ Show Notes: 0:00 Intro 1:30 Up to 95% of people with cardiac disease are insulin resistant. 4:45 Processed foods and high carbs are the two primary drivers of metabolic disease, the primary driver of heart disease. 6:53 Insulin resistance damages blood vessels. 11:18 Exercise is indirectly helpful in preventing atherosclerosis. 13:10 The better you can maintain muscle as you age, the better you can deal with the aging process. 14:30 It is possible to reverse atherosclerosis. 16:30 Tests: coronary artery calcium scan (CAC) and coronary CT angiogram (CCTA). 18:30 People in their 30s and 40s now end up on the cardiac operating table. 20:30 High LDL may not be dangerous in a person who is metabolically healthy. 21:00 The quality of your LDL particles is important. 22:54 90% of adults are metabolically unhealthy, so their high LDL is likely dangerous. 24:05 Statin use for over 10 years increases your risk of developing insulin resistance and type 2 diabetes, primary drivers of heart disease. 26:30 Inflammation is an important part of the development of heart disease. 27:40 High blood pressure root cause is insulin resistance/metabolic disease. 31:41 Ferritin testing measures total body iron stores. It is also an inflammation marker. 35:50 Linoleic acid LDL oxidation hypothesis 37:30 Plant-based diets 40:25 Lowering your intake of omega 6 improves your omega 3 index. 41:10 Low vitamin D 42:00 Sun exposure has been misunderstood. 44:10 Triglycerides is a higher risk than LDL. 48:30 Bioidentical hormones are superior to synthetic. 50:03 Low testosterone is a risk factor for heart disease. 53:10 Heart surgery does not fix the underlying problem.      

En este capítulo, Pacho llegó muy feliz al programa y le dedicó un acróstico al productor, y también, estudiantes de dos universidades se hacen tendencia en redes sociales. Lo acompañamos a donde quiera con este pódcast tan coquette.

Episode 2435 - On this Friday's show Vinnie Tortorich welcomes back Dave Feldman to discuss Citizen Science and its LMHR study, and more. https://vinnietortorich.com/2024/01/citizen-science-with-dave-feldman-episode-2435 PLEASE SUPPORT OUR SPONSORS   YOU CAN WATCH THIS EPISODE ON YOUTUBE - Making Noise Dave explains a recent double-blind study and the recent data shared with him. (5:00) He defines an LMHR (Lean Mass Hyper Responder) as high LDL, high HDL, and low triglycerides. He explains his background to folks unfamiliar with him. (7:00) Dave is an engineer and noticed a pattern or system. He shares the study with LMHR was about and some of its challenges. Awareness of LMHR is growing, so it should be studied even further. Funding such studies is difficult; however, the low-carb community has stepped up. The study analyzes how much LDL independently induces a high rate of atherosclerosis (lesions on the artery walls). (23:00) The participants are part of a year-long study that will measure plaque volume and soft plaque progression. The majority of studies done are on people who already have various diseases. (32:00) Dave would like to see a larger percentage of studies done on healthy populations to find a common baseline of biomarkers. Dave shares some information about Dr. Matthew Budoff's presentation that may be more useful to view on YouTube. To view the slides go to Vinnie's YouTube channel for this episode to view the discussion. (36:00) It discusses the quantifying of atherosclerosis with CCTA. Dave goes through the slides and explains the findings. A total plaque sore is discussed. (48:45) LDL cholesterol does not correlate with the progression of plaque. The caveat: this is preliminary data and more information needs to be collected. (56:50) Both Dave and Vinnie hope that the funding they have received for projects will help people learn and be empowered. (1:01:00) You can help fund such studies through Citizen Science at . [the_ad id="20253"] PURCHASE BEYOND IMPOSSIBLE (2022) The documentary launched on January 11! Order it TODAY! This is Vinnie's third documentary in just over three years. Get it now on Apple TV (iTunes) and/or Amazon Video! Link to the film on Apple TV (iTunes):  Then, Share this link with friends, too! It's also now available on Amazon (the USA only for now)!  Visit my new Documentaries HQ to find my films everywhere: REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere: Then, please share my fact-based, health-focused documentary series with your friends and family. The more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: Then, please share my fact-based, health-focused documentary series with your friends and family. The more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter!  

Why the latest results on CAC scores and CCTA don't add anything meaningful to the LMHR theory. What should they have checked instead? In fact, the new CAC results actually muddy the waters and confuse those who don't know any better. https://dralo.net/links

Deep dive into imaging modalities that can actually show soft plaque. A deep dive into invasive and non invasive techniques. Comparing CT angiograms CCTA, calcium score CAC, coronary angiography cardiac cath, intravascular ultrasound IVUS, optical coherence tomography OCT, 3D vascular ultrasound 3DVUS, versus lipid levels. PESA, PRECAD, CARDIA trials. https://dralo.net/links

Mike reached out to Dr. Baker to share his transformative health journey over the last seven years. From childhood, he experienced chronic stomach issues and anxiety related to his condition. Despite being an active athlete in college football and rugby, his gastrointestinal problems persisted into his 30s. As a Firefighter/Paramedic, he faced challenges due to his morning routines caused by these issues. After numerous medical tests and a late diagnosis of ulcerative colitis in his late 20s, Mike turned to dietary changes for relief. Transitioning from gluten-free to paleo, then to keto, he eventually found significant improvement by following a diet inspired by a Joe Rogan podcast, focusing on red meat and eggs.  Timestamps: 00:00:00 Trailer and introduction. 00:05:26 College linebacker struggled with weight and migraines. 00:07:59 Bathroom troubles, embarrassment, doctor visits, unchanged diet. 00:10:12 Quit drinking alcohol, did Whole30, lost weight. 00:15:06 Disastrous gut reactions led to lifelong medication. 00:17:36 Same outcomes, debates, cholesterol, no statins. 00:22:02 Bringing own skillet, overcoming obstacles, stomach issues. 00:25:14 Butter, salt on fish; no soy sauce. Wife's dietary changes for hormone health. 00:26:58 Limited vegan options in department meals. 00:32:55 Carnivore and keto diets gaining popularity. 00:34:25 Fruit sugar tasted amazing, then inflammation and pain. 00:38:58 Carnivore diet for health issues. 00:42:20 High obesity rates. 00:45:21 Limited food options at wedding, ate beforehand. 00:49:41 Uphill battle, impact people. 00:52:18 Encouraging study on CCTA angiography. 00:54:12 Where to find Mike. See open positions at Revero: https://jobs.lever.co/Revero/ Join Carnivore Diet for a free 30 day trial: https://carnivore.diet/join/ Carnivore Shirts: https://merch.carnivore.diet Subscribe to our Newsletter: https://carnivore.diet/subscribe/ . ‪#revero #shawnbaker #Carnivorediet #MeatHeals #HealthCreation   #humanfood #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree  ‪

Take Home Points: A CCTA is an anatomic test to determine if a patient has normal coronary arteries, non-obstructive disease, or obstructive disease. The warranty period for a CCTA is anywhere from 3-10 years depending on the characteristics of the plaque.  A nuclear stress test is a functional study that allows for ischemia-driven management. The ... Read more The post REBEL Core Cast 111.0 – Cardiac Testing appeared first on REBEL EM - Emergency Medicine Blog.

Is there any way to really see soft plaque? Yes, there is. What do calcium scores mean and why do we have calcium score? What about coronary CT angiogram (CCTA)? What about the Cleerly Heart Scan? https://dralo.net/cholesterol https://dralo.net/links